CN108851089A - Alleviate the tablet and its preparation process of physical fatigue - Google Patents
Alleviate the tablet and its preparation process of physical fatigue Download PDFInfo
- Publication number
- CN108851089A CN108851089A CN201811062445.7A CN201811062445A CN108851089A CN 108851089 A CN108851089 A CN 108851089A CN 201811062445 A CN201811062445 A CN 201811062445A CN 108851089 A CN108851089 A CN 108851089A
- Authority
- CN
- China
- Prior art keywords
- parts
- weight
- tablet
- physical fatigue
- alleviating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 29
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 82
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims abstract description 73
- 239000002994 raw material Substances 0.000 claims abstract description 49
- 229960003080 taurine Drugs 0.000 claims abstract description 41
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims abstract description 37
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims abstract description 37
- 229960001948 caffeine Drugs 0.000 claims abstract description 37
- 239000000463 material Substances 0.000 claims abstract description 28
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 claims abstract description 25
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 23
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229960000367 inositol Drugs 0.000 claims abstract description 19
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims abstract description 19
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims abstract description 19
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229960003966 nicotinamide Drugs 0.000 claims abstract description 16
- 235000005152 nicotinamide Nutrition 0.000 claims abstract description 16
- 239000011570 nicotinamide Substances 0.000 claims abstract description 16
- 239000000284 extract Substances 0.000 claims abstract description 9
- 239000003826 tablet Substances 0.000 claims description 46
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 34
- 239000000843 powder Substances 0.000 claims description 27
- 239000012153 distilled water Substances 0.000 claims description 19
- 235000019441 ethanol Nutrition 0.000 claims description 17
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 16
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 15
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 15
- 241001330002 Bambuseae Species 0.000 claims description 15
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 15
- 241000270295 Serpentes Species 0.000 claims description 15
- 239000011425 bamboo Substances 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 14
- 239000000243 solution Substances 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 13
- 238000010790 dilution Methods 0.000 claims description 12
- 239000012895 dilution Substances 0.000 claims description 12
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 11
- 235000020985 whole grains Nutrition 0.000 claims description 10
- 239000007910 chewable tablet Substances 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 9
- IQQRAVYLUAZUGX-UHFFFAOYSA-N 1-butyl-3-methylimidazolium Chemical compound CCCCN1C=C[N+](C)=C1 IQQRAVYLUAZUGX-UHFFFAOYSA-N 0.000 claims description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- 230000001376 precipitating effect Effects 0.000 claims description 8
- 238000002390 rotary evaporation Methods 0.000 claims description 8
- 239000011780 sodium chloride Substances 0.000 claims description 8
- 239000007787 solid Substances 0.000 claims description 8
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 7
- 239000011716 vitamin B2 Substances 0.000 claims description 7
- 238000004108 freeze drying Methods 0.000 claims description 6
- 239000011715 vitamin B12 Substances 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 108091005804 Peptidases Proteins 0.000 claims description 5
- 230000009849 deactivation Effects 0.000 claims description 5
- 239000008236 heating water Substances 0.000 claims description 5
- 239000004365 Protease Substances 0.000 claims description 4
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 4
- 239000000428 dust Substances 0.000 claims description 4
- 239000011259 mixed solution Substances 0.000 claims description 4
- 239000012074 organic phase Substances 0.000 claims description 4
- 239000012071 phase Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 101800000263 Acidic protein Proteins 0.000 claims description 3
- 238000005341 cation exchange Methods 0.000 claims description 3
- 238000004821 distillation Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 2
- 238000007873 sieving Methods 0.000 claims 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 239000005864 Sulphur Substances 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 235000019504 cigarettes Nutrition 0.000 claims 1
- 230000036541 health Effects 0.000 abstract description 4
- 235000013305 food Nutrition 0.000 description 31
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 24
- 235000013373 food additive Nutrition 0.000 description 18
- 239000002778 food additive Substances 0.000 description 18
- 241000699666 Mus <mouse, genus> Species 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- 239000000047 product Substances 0.000 description 13
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 12
- 235000019158 vitamin B6 Nutrition 0.000 description 12
- 229940011671 vitamin b6 Drugs 0.000 description 12
- 230000009182 swimming Effects 0.000 description 11
- 238000000034 method Methods 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 230000010412 perfusion Effects 0.000 description 6
- 230000005180 public health Effects 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000000295 complement effect Effects 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 102000004420 Creatine Kinase Human genes 0.000 description 4
- 108010042126 Creatine kinase Proteins 0.000 description 4
- 229920002527 Glycogen Polymers 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 229940096919 glycogen Drugs 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000002440 hepatic effect Effects 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 235000019419 proteases Nutrition 0.000 description 3
- 229960004793 sucrose Drugs 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 229940085891 caffeine 100 mg Drugs 0.000 description 2
- -1 caffeine compound Chemical class 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 229940098086 niacinamide 30 mg Drugs 0.000 description 2
- 210000000963 osteoblast Anatomy 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000000859 sublimation Methods 0.000 description 2
- 230000008022 sublimation Effects 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- 229940046664 taurine 500 mg Drugs 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 235000014101 wine Nutrition 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- MIJDSYMOBYNHOT-UHFFFAOYSA-N 2-(ethylamino)ethanol Chemical compound CCNCCO MIJDSYMOBYNHOT-UHFFFAOYSA-N 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101100460719 Mus musculus Noto gene Proteins 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 238000000944 Soxhlet extraction Methods 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 239000010425 asbestos Substances 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 229940046011 buccal tablet Drugs 0.000 description 1
- 239000006189 buccal tablet Substances 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- OOTFVKOQINZBBF-UHFFFAOYSA-N cystamine Chemical compound CCSSCCN OOTFVKOQINZBBF-UHFFFAOYSA-N 0.000 description 1
- 229940099500 cystamine Drugs 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019225 fermented tea Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000002608 ionic liquid Substances 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229910052895 riebeckite Inorganic materials 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- AVPCPPOOQICIRJ-UHFFFAOYSA-L sodium glycerol 2-phosphate Chemical compound [Na+].[Na+].OCC(CO)OP([O-])([O-])=O AVPCPPOOQICIRJ-UHFFFAOYSA-L 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a kind of tablets for alleviating physical fatigue, are mainly prepared from the following raw materials in parts by weight tablet:400-500 parts of taurine, 90-110 parts of caffeine, 140-160 parts of l-Lysine hydrochloride, 45-55 parts of inositol, 30-40 parts of niacinamide, vitamin B64-6 parts.The invention also discloses a kind of preparation processes of tablet for alleviating physical fatigue.Tablet is made in health care product by initiative of the invention, extracts taurine and caffeine from natural materials, and highly-safe in artificial synthesized, the product of preparation can significantly alleviate physical fatigue.
Description
Technical field
The present invention relates to food technology fields.It is more particularly related to it is a kind of alleviate physical fatigue tablet and
Its preparation process.
Background technique
As rhythm of life is constantly accelerated, people's body overload operation, physical strength is on a declining curve, will lead to body for a long time
Body resistance and immunity degradation.To alleviate physical fatigue, improves people's sub-health state, occur many healthy medicated wines in the market
And health drink.Present young people wishes to improve constitution but to healthy medicated wine and health drink presentation resistance mood, it is believed that
Liquid medicine contains alcohol, and beverage contains sugar mostly, and long-term drinking is not conducive to good health.
Summary of the invention
It is an object of the invention to solve at least the above problems, and provide the advantages of at least will be described later.
It is a still further object of the present invention to provide a kind of tablet and its preparation process for alleviating physical fatigue, initiative will
Tablet is made in health care product, and taurine and caffeine are extracted from natural materials, highly-safe in artificial synthesized, the product energy of preparation
Enough significant alleviation physical fatigues.
In order to realize these purposes and other advantages according to the present invention, a kind of tablet for alleviating physical fatigue is provided,
Mainly it is prepared from the following raw materials in parts by weight tablet:400-500 parts of taurine, 90-110 parts of caffeine, l-Lysine hydrochloride
140-160 parts, 45-55 parts of inositol, 30-40 parts of niacinamide, vitamin B64-6 parts.
Preferably, mainly it is prepared from the following raw materials in parts by weight tablet:400-500 parts of taurine, caffeine 90-
110 parts, 140-160 parts of l-Lysine hydrochloride, 45-55 parts of inositol, 30-40 parts of niacinamide, vitamin B64-6 parts, L-carnitine
90-110 parts, vitamin B120.004-0.006 parts, vitamin B28-12 parts.
Preferably, the tablet is chewable tablets.
Preferably, mainly it is prepared from the following raw materials in parts by weight chewable tablets:460 parts of taurine, 100 parts of caffeine,
150 parts of l-Lysine hydrochloride, 50 parts of inositol, 35 parts of niacinamide, vitamin B65 parts, 100 parts of L-carnitine, vitamin B12
0.005 part, vitamin B210 parts.
It preferably, further include the auxiliary material of 250-350 parts by weight.
A kind of preparation process of tablet that alleviating physical fatigue, the raw material of above-mentioned parts by weight is sieved, powder is mixed to obtain,
Pelletized with the ethanol water of powder gross weight 20%, dry, auxiliary material is sieved by whole grain, total mix, tabletting, bottling to get.
Preferably, the raw material of above-mentioned parts by weight is crossed into 80 meshes, mixing 30min obtains powder, with powder gross weight 20%
85wt.% ethanol water granulation, cross 20 meshes, dry, 350-450 parts by weight auxiliary material is crossed 80 meshes, total mix by whole grain
5min, tabletting, bottling to get.
Preferably, the preparation method of the taurine is:Fish-bone is processed into fishbone dust, the distillation of 2 times of weight is added
Water, constant temperature decocts 2h at 100 DEG C, filtering, and filter residue is added etc. to the distilled water of weight, and constant temperature decocts 2h at 100 DEG C, again mistake
Filter merges filtrate twice, and concentrated by rotary evaporation to solid content is higher than 50%, the ethyl alcohol of the weight such as addition into concentrate, then
Be added protease, adjust pH to 8,40 DEG C of heating water bath 2h, 100 DEG C of water-bath enzyme deactivations, centrifugal filtering liquid, adjust pH to 3, go to deacidify
Property albumen precipitation, adjust pH to 10, removal basic protein precipitating, be added 10 times of weight distilled water, adjust pH to 5, must dilute
Dilution is injected light room by liquid, by etc. the 0.25wt.%NaCl solution of weight inject dense room, by etc. the distilled water of weight inject
Pole room, control light room, dense room water flow be 400000L/h, control pole room water flow be 200L/h, with the speed of 2V/min
Increase voltage to 20V, when electric current no longer reduces, adjusts voltage, electric current 0, dilution carries out cationic exchange by treated
Processing, collect efflux, be concentrated under reduced pressure, freeze-drying to get.
Preferably, the preparation method of the caffeine is:Green bamboo snake is processed into green bamboo snake powder, 10 times of weight are added
Distilled water, adding mass ratio is 1:The mixture of 1 CaO and MgO, stirring to paste are dried, and crush, 20 times of quality are added
Volume ratio be 6:1 ethyl alcohol and [BMIM]+[BH4]-Mixed solution extract 2 times, Extracting temperature is 80 DEG C, and extraction time is
2h, combined extract are distilled ethyl alcohol and [BMIM]+[BH4]-It steams, concentrated by rotary evaporation to solid content is higher than 50%, with just
Hexane extraction, the sodium chloride solution of 5wt.% is added in water phase, is extracted with chloroform, merges organic phase, is concentrated under reduced pressure, and freezing is dry
It is dry to get.
The present invention is include at least the following beneficial effects:
The first, tablet is made in raw material by the present invention, is had initiative, is overcome tradition and be prepared into caused by beverage or liquid medicine
Prejudice is taken, formula functional of the invention, additive are few, have excellent antifatigue effect;Chewable tablets promotes drug to exist
Intracorporal dissolution and absorption, for the selection of more preferably tablet;The auxiliary material for adding the amount can correct the dose and specification of major ingredient;This
Invention is overcome using the ethanol water granulation of the 85wt.% of powder gross weight 20% and is prepared tablet by taurine and caffeine
Technical difficulty;
The second, the present invention uses natural product extraction taurine, selects fish-bone to extract, avoids conventional marine organisms from being made black
Color product causes the later period using a large amount of sour acidolysis, and strong acid hydrolysis is easily destroyed taurine, the taurine molecule being present in fish-bone
It is not easy free isolation, decoction makes the free isolation of taurine, enters solution, and content of taurine is low, still contains a large amount of amino acid, more
Peptide, soluble protein, then digested, enzyme deactivation, the taurine in the assisted extraction fish-bone of proteinase activity center, it adjusts pH and goes
Except acid albumen precipitation and basic protein precipitate, the anion-permeable cavity block of light room enters dense room, but dense indoor anion is not
Anode membrane can be penetrated, therefore stays in dense interior;Cation is migrated to cathode, and enters dense room by anode membrane, and dense indoor cation is but
Cavity block cannot be penetrated, therefore is stayed in dense room, the salt ionic concentration of dilution is gradually small in light room, and electric current is gradually decrease to stablize,
The purity of taurine can reach 97%;
Third, the present invention use natural product extraction caffeine, select non-fermented tea green bamboo snake, content of caffeine is high, CaO
It is reacted with MgO with the gallic acid that tannic acid in green bamboo snake or hydrolysis generate and generates the calcium salt being impermissible for or magnesium salts solidification precipitating,
Keep caffeine free, it is high compared to single extractant extracting caffeine yield with the compounding of acetone and ionic liquid, electrolysis is added
Matter sodium chloride increases polarity, and extraction solution is avoided to form milkiness shape, shortens separation time.
Further advantage, target and feature of the invention will be partially reflected by the following instructions, and part will also be by this
The research and practice of invention and be understood by the person skilled in the art.
Specific embodiment
The present invention will be further described in detail below with reference to the embodiments, to enable those skilled in the art referring to specification
Text can be implemented accordingly.
It should be appreciated that such as " having ", "comprising" and " comprising " term used herein do not allot one or more
The presence or addition of a other elements or combinations thereof.
It should be noted that experimental method described in following embodiments is unless otherwise specified conventional method, institute
Reagent and material are stated, unless otherwise specified, is commercially obtained.
<Example 1>
A kind of tablet for alleviating physical fatigue, is mainly prepared from the following raw materials in parts by weight tablet:Taurine 400mg,
Caffeine 90mg, l-Lysine hydrochloride 140mg, inositol 45mg, niacinamide 30mg, vitamin B64mg, starch, starch slurry, cunning
Mountain flour etc. complements to 1200mg.
The raw material of above-mentioned parts by weight is sieved, powder is mixed to obtain, is pelletized, is done with the ethanol water of powder gross weight 20%
Dry, auxiliary material is sieved by whole grain, total mix, tabletting, bottles to get oral ordinary tablet.
The raw material standard of taurine is:GB 14759-2010 national food safety standard food additives taurine, coffee
The raw material standard of cause is:GB 14758-2010 national food safety standard food additives caffeine, the original of l-Lysine hydrochloride
Material standard is:GB 1903.1-2015 national food safety standard food enrichment l-Lysine hydrochloride, the raw material of inositol
Standard is:The Ministry of Public Health's No. 19 bulletin in 2011, the raw material standard of niacinamide are:《Chinese Pharmacopoeia》Two, the original of vitamin B6
Material standard is:GB 14753-2010 national food safety standard food additives vitamin B6 (puridoxine hydrochloride), manufactured production
Product 0.6g/ piece, 2 times a day, 1 tablet once.
<Example 2>
A kind of tablet for alleviating physical fatigue, is mainly prepared from the following raw materials in parts by weight tablet:Taurine 500mg,
Caffeine 110mg, l-Lysine hydrochloride 160mg, inositol 55mg, niacinamide 40mg, vitamin B66mg, starch, sucrose, paste
Essence, acrylic resin etc. complement to 1200mg.
The raw material of above-mentioned parts by weight is sieved, powder is mixed to obtain, is pelletized, is done with the ethanol water of powder gross weight 20%
Dry, auxiliary material is sieved by whole grain, total mix, tabletting, bottles to get enteric coatel tablets.
The raw material standard of taurine is:GB 14759-2010 national food safety standard food additives taurine, coffee
The raw material standard of cause is:GB 14758-2010 national food safety standard food additives caffeine, the original of l-Lysine hydrochloride
Material standard is:GB 1903.1-2015 national food safety standard food enrichment l-Lysine hydrochloride, the raw material of inositol
Standard is:The Ministry of Public Health's No. 19 bulletin in 2011, the raw material standard of niacinamide are:《Chinese Pharmacopoeia》Two, the original of vitamin B6
Material standard is:GB 14753-2010 national food safety standard food additives vitamin B6 (puridoxine hydrochloride), manufactured production
Product 0.6g/ piece, 2 times a day, 1 tablet once.
<Example 3>
A kind of tablet for alleviating physical fatigue, is mainly prepared from the following raw materials in parts by weight chewable tablets:Taurine
460mg, caffeine 100mg, l-Lysine hydrochloride 150mg, inositol 50mg, niacinamide 35mg, vitamin B65mg, magnesium stearate
Complement to 1200mg.
The raw material of above-mentioned parts by weight is sieved, powder is mixed to obtain, is pelletized, is done with the ethanol water of powder gross weight 20%
Dry, auxiliary material is sieved by whole grain, total mix, tabletting, bottles to get chewable tablets.
The raw material standard of taurine is:GB 14759-2010 national food safety standard food additives taurine, coffee
The raw material standard of cause is:GB 14758-2010 national food safety standard food additives caffeine, the original of l-Lysine hydrochloride
Material standard is:GB 1903.1-2015 national food safety standard food enrichment l-Lysine hydrochloride, the raw material of inositol
Standard is:The Ministry of Public Health's No. 19 bulletin in 2011, the raw material standard of niacinamide are:《Chinese Pharmacopoeia》Two, the original of vitamin B6
Material standard is:GB 14753-2010 national food safety standard food additives vitamin B6 (puridoxine hydrochloride), manufactured production
Product 0.6g/ piece, 2 times a day, 1 tablet once.
<Example 4>
A kind of tablet for alleviating physical fatigue, is mainly prepared from the following raw materials in parts by weight tablet:Taurine 400mg,
Caffeine 90mg, l-Lysine hydrochloride 140mg, inositol 45mg, niacinamide 30mg, vitamin B64mg, L-carnitine 90mg, dimension
Raw element B120.004mg, vitamin B28mg, starch, citric acid, malic acid, talcum powder complement to 1200mg.
The raw material of above-mentioned parts by weight is sieved, powder is mixed to obtain, is pelletized, is done with the ethanol water of powder gross weight 20%
Dry, auxiliary material is sieved by whole grain, total mix, tabletting, bottles to get effervescent tablet.
The raw material standard of taurine is:GB 14759-2010 national food safety standard food additives taurine, coffee
The raw material standard of cause is:GB 14758-2010 national food safety standard food additives caffeine, the original of l-Lysine hydrochloride
Material standard is:GB 1903.1-2015 national food safety standard food enrichment l-Lysine hydrochloride, the raw material of inositol
Standard is:The Ministry of Public Health's No. 19 bulletin in 2011, the raw material standard of niacinamide are:《Chinese Pharmacopoeia》Two, the original of vitamin B6
Material standard is:GB 14753-2010 national food safety standard food additives vitamin B6 (puridoxine hydrochloride), manufactured production
Product 0.6g/ piece, 2 times a day, 1 tablet once.
<Example 5>
A kind of tablet for alleviating physical fatigue, is mainly prepared from the following raw materials in parts by weight tablet:Taurine 500mg,
Caffeine 110mg, l-Lysine hydrochloride 160mg, inositol 55mg, niacinamide 40mg, vitamin B66mg, L-carnitine 110mg,
Vitamin B120.006mg, vitamin B212mg, starch, sucrose, cane sugar powder, mannitol etc. complement to 1200mg.
The raw material of above-mentioned parts by weight is sieved, powder is mixed to obtain, is pelletized, is done with the ethanol water of powder gross weight 20%
Dry, auxiliary material is sieved by whole grain, total mix, tabletting, bottles to get buccal tablet.
The raw material standard of taurine is:GB 14759-2010 national food safety standard food additives taurine, coffee
The raw material standard of cause is:GB 14758-2010 national food safety standard food additives caffeine, the original of l-Lysine hydrochloride
Material standard is:GB 1903.1-2015 national food safety standard food enrichment l-Lysine hydrochloride, the raw material of inositol
Standard is:The Ministry of Public Health's No. 19 bulletin in 2011, the raw material standard of niacinamide are:《Chinese Pharmacopoeia》Two, the original of vitamin B6
Material standard is:GB 14753-2010 national food safety standard food additives vitamin B6 (puridoxine hydrochloride), manufactured production
Product 0.6g/ piece, 2 times a day, 1 tablet once.
<Example 6>
A kind of tablet for alleviating physical fatigue, is mainly prepared from the following raw materials in parts by weight chewable tablets:Taurine
460mg, caffeine 100mg, l-Lysine hydrochloride 150mg, inositol 50mg, niacinamide 35mg, vitamin B65mg, L-carnitine
100mg, vitamin B120.005mg, vitamin B210mg, magnesium stearate complement to 1200mg.
The raw material of above-mentioned parts by weight is sieved, powder is mixed to obtain, is pelletized, is done with the ethanol water of powder gross weight 20%
Dry, auxiliary material is sieved by whole grain, total mix, tabletting, bottles to get chewable tablets.
The raw material standard of taurine is:GB 14759-2010 national food safety standard food additives taurine, coffee
The raw material standard of cause is:GB 14758-2010 national food safety standard food additives caffeine, the original of l-Lysine hydrochloride
Material standard is:GB 1903.1-2015 national food safety standard food enrichment l-Lysine hydrochloride, the raw material of inositol
Standard is:The Ministry of Public Health's No. 19 bulletin in 2011, the raw material standard of niacinamide are:《Chinese Pharmacopoeia》Two, the original of vitamin B6
Material standard is:GB 14753-2010 national food safety standard food additives vitamin B6 (puridoxine hydrochloride), manufactured production
Product 0.6g/ piece, 2 times a day, 1 tablet once.
<Example 7>
A kind of tablet for alleviating physical fatigue, is formulated and preparation method is with example 6, the difference is that, the preparation side of taurine
Method is:Fish-bone is processed into fishbone dust, the distilled water of 2 times of weight is added, constant temperature decocts 2h at 100 DEG C, and filter residue is added for filtering
Etc. weight distilled water, constant temperature decocts 2h at 100 DEG C, filters again, merges filtrate twice, concentrated by rotary evaporation to solid content
It higher than 50%, the ethyl alcohol of weight such as is added into concentrate, adds protease, adjust pH to 8,40 DEG C of heating water bath 2h, 100
DEG C water-bath enzyme deactivation, centrifugal filtering liquid adjust pH to 3, removal acidic protein precipitating, adjust pH to 10, removal basic protein precipitating,
Be added the distilled water of 10 times of weight, adjust pH to 5, obtain dilution, dilution is injected into light room, by etc. weight 0.25wt.%
NaCl solution injects dense room, by etc. the distilled water of weight inject pole room, control light room, the water flow of dense room is 400000L/h, control
The water flow of pole room processed is 200L/h, increases voltage to 20V with the speed of 2V/min, when electric current no longer reduces, adjusts voltage, electricity
Stream is 0, and treated dilution is carried out cation exchange treatment, efflux is collected, is concentrated under reduced pressure, freeze-drying to get.
Identified, the infrared absorption of taurine made from example 7 and the infrared absorption of taurine standard items are completely the same,
3209cm-1、3048cm-1Place is N-H stretching vibration, 2969cm-1Place is C-H stretching vibration, 1617cm-1、1585cm-1、
1513cm-1、1215cm-1、1182cm-1Place is C-S, S=O stretching vibration.
The color for the taurine that example 7 is extracted is that white to cheese color crystallizes, yield 93%, purity 97%, yield
For 3.8g/kg fish-bone.
The yield of example 7 is apparently higher than conventional chemical synthesis method (2- ethylaminoethanol synthetic method 83%, cystamine oxidative synthesis
Method 87.6%, N- vinyl alkyl amide synthetic method 89%).
<Example 8>
A kind of tablet for alleviating physical fatigue, is formulated and preparation method is with example 6, the difference is that, the preparation side of caffeine
Method is:Green bamboo snake is processed into green bamboo snake powder, the distilled water of 10 times of weight is added, adding mass ratio is 1:1 CaO and MgO
Mixture, stirring dries to paste, crushes, and the volume ratio that 20 times of quality are added is 6:1 ethyl alcohol and [BMIM]+[BH4]-'s
Mixed solution extracts 2 times, and Extracting temperature is 80 DEG C, extraction time 2h, and combined extract is distilled ethyl alcohol and [BMIM]+
[BH4]-It steams, concentrated by rotary evaporation to solid content is higher than 50%, and with n-hexane extraction, the chlorination of 5wt.% is added in water phase
Sodium solution is extracted with chloroform, merge organic phase, be concentrated under reduced pressure, freeze-drying to get.
Identified, caffeine infrared absorption made from example 8 and the infrared absorption of caffeine standards are completely the same,
2954cm-1Place is CH3C-H stretching vibration, 1430cm-1、3110cm-1Place is N-CH3Upper C-H bending vibration, 1664cm-1、
1702cm-1Place is>CO stretching vibration, 1280cm-1Place is C-N stretching vibration.
The color for the caffeine that example 8 is extracted is white crystals, and yield is 188mg/5g green bamboo snake.
<Example 9>
A kind of tablet for alleviating physical fatigue, is formulated and preparation method is with example 6, the difference is that,
The preparation method of taurine is:Fish-bone is processed into fishbone dust, the distilled water of 2 times of weight, constant temperature at 100 DEG C is added
Decoct 2h, the distilled water of weight is added etc. in filter residue by filtering, and constant temperature decocts 2h at 100 DEG C, filters again, merges filter twice
Liquid, concentrated by rotary evaporation to solid content are higher than 50%, and into concentrate, the ethyl alcohol of the weight such as addition, adds protease, adjust
PH to 8,40 DEG C of heating water bath 2h, 100 DEG C of water-bath enzyme deactivations, centrifugal filtering liquid adjust pH to 3, and removal acidic protein precipitating is adjusted
PH to 10, removal basic protein precipitating, is added the distilled water of 10 times of weight, adjusts pH to 5, obtain dilution, dilution is injected
Light room, by etc. the 0.25wt.%NaCl solution of weight inject dense room, by etc. the distilled water of weight inject pole room, control light room, dense
The water flow of room is 400000L/h, and the water flow for controlling pole room is 200L/h, increases voltage to 20V, electricity with the speed of 2V/min
When stream no longer reduces, voltage, electric current 0 are adjusted, by treated, dilution carries out cation exchange treatment, efflux is collected,
Be concentrated under reduced pressure, freeze-drying to get;
The preparation method of caffeine is:Green bamboo snake is processed into green bamboo snake powder, the distilled water of 10 times of weight is added, adds
Mass ratio is 1:The mixture of 1 CaO and MgO, stirring to paste are dried, and are crushed, and the volume ratio that 20 times of quality are added is 6:1
Ethyl alcohol and [BMIM]+[BH4]-Mixed solution extract 2 times, Extracting temperature be 80 DEG C, extraction time 2h, combined extract,
It distills ethyl alcohol and [BMIM]+[BH4]-It steams, concentrated by rotary evaporation to solid content is higher than 50%, with n-hexane extraction, in water phase
It is middle be added 5wt.% sodium chloride solution, extracted with chloroform, merge organic phase, be concentrated under reduced pressure, freeze-drying to get.
<Comparative example 1>
Using alcohol extracting sublimed method in green bamboo snake extracting caffeine:5g tealeaves is taken, the filter paper casing of Soxhlet extractor is packed into
It is interior, the ethyl alcohol of 40mL95% is added in 250mL round-bottomed flask, heating water bath makes hot ethanol repeatedly dissolve the coffee in tealeaves
Cause, extraction times 90min stop heating.After slightly cooling down, repacks Soxhlet extraction device into distilling apparatus, remain 5 in cucurbit
Until~10mL blackish green extracting solution.Raffinate is poured into evaporating dish, adds 3~4g calcium lime powder, is evaporated in water-bath.Then will
Evaporating dish is moved on asbestos gauge and is heated, and by a thorn, there are many circle filter paper of aperture to cover on evaporating dish, then covers a drying
Glass funnel (a little cotton of filler neck part plug), heating sublimation.When occurring white, needle-shaped crystals on filter paper, make rate of sublimation
Slow down as far as possible, to improve crystallization purity.When brown fume occurs in glass funnel, indicates that distillation finishes, stop heating.It is cooling
Afterwards, it opens funnel and filter paper, collects on filter paper and the caffeine of inner wall of hopper.
In comparative example 2, the siphon pipe price of Soxhlet extractor is higher, is easy breakage, the color of the caffeine extracted
It is impure for yellow crystal, it is recrystallized, yield is 123mg/5g green bamboo snake.
<Comparative example 2>
A kind of tablet for alleviating physical fatigue, is formulated and preparation method is with example 8, the difference is that, the preparation of caffeine
Raw material is the Iron Guanyin or Dragon Well tea of equivalent.
For test result it is found that the yield of Iron Guanyin is 88mg/5g Iron Guanyin, imperial well yield is 65mg/5g Dragon Well tea, remote low
The yield 188mg/5g green bamboo snake of green bamboo snake in example 8.
<Alleviate effort trial>
Selecting weight is mouse 160 of 18~22g, half male and half female.Mouse is randomly divided into four big groups, per big group 40
It only, is daily 0.2g/10g to mouse administered volume through stomach perfusion, successive administration 20d, test group 1 feeds the preparation of example 3
Product, test group 2 feed the product of the preparation of example 6, and control group feeds commercially available Maotai-flavor liquor, and blank group feeds water.Last perfusion
It is separated into four groups, 10 mouse of every group for every group afterwards.When major group of mouse to be carried out according to four groups to swimming with a load attached to the body respectively
Between, serum urea nitrogen, hepatic glycogen and 4 index determinings of Serum Creatine Kinase of Patients, the difference of indices between comparative group.
1.1 walking weight load
Mouse last perfusion is placed in swimming trunk, depth of water 50cm, water temperature (25 ± 0.5) DEG C, by 5% body of root of the tail portion load
The mouse of weight lead counterweight is placed in swimming trunk went swimming, and record is unable to emersion water to head whole submerged 10s since swimming
The time in face is the mice burden swimming time as mouse longest swimming time.Test result is as shown in table 1, it can be seen that
2 mouse power of test group exhausts swimming, and obviously performance is the most active, and 1 mouse power of test group exhausts swimming, and obviously performance is more active, tests
1,2 swimming times of group are longer than control group (P < 0.05), and considerably longer than blank group (P < 0.01).
The measurement of 1.2 serum urea nitrogens
After mouse last perfusion, depth of water 50cm, water temperature (25 ± 0.5) DEG C, mouse not swimming with a load attached to the body 90min, rest 60min
After take a blood sample, by kit method measure urea in serum nitrogen content.Test result is as shown in table 1, it can be seen that test group 1,2
Urea nitrogen is lower than control group (P < 0.01) in mice serum, and substantially less than blank group (P < 0.01).
The measurement of 1.3 hepatic glycogen
After mouse last perfusion 30min, mouse is put to death, liver is taken to be blotted after physiological saline rinses with filter paper, it is accurate to claim
It takes and measures hepatic glycogen content by kit method after liver.Test result is as shown in table 1, it can be seen that test group 1,2 mouse blood
Glycogen is higher than control group (P < 0.01) in clear, and is significantly higher than blank group (P < 0.01).
The measurement of creatine phosphokinase in 1.4 serum
It takes a blood sample after mouse last perfusion 30min, by creatine phosphokinase vigor in kit method measurement serum.Test knot
Fruit is as shown in table 1, it can be seen that creatine phosphokinase is lower than control group (P < 0.01) in test group 1,2 mice serums, and shows
It writes and is lower than blank group (P < 0.01).
Table 1
<Cell proliferation test>
It selects newborn mice (< is for 24 hours), puts to death animal, separate osteoblast-like cells group, cultured osteoblast-like cells in vitro to shape
Stablize, be in fiber bundle-like, triangle, cell connects each other closely.By osteoblast with 1 × 105A/mL cell density, every hole
800 μ inoculation is added culture solution (containing vitamin C and sodium β-glycerophosphate), is divided into four groups of inoculations after cell is adherent, prepared by example 6
Product, example 9 prepare product, taurine and caffeine compound preparation (mass ratio 5:1), blank group, every 3d change liquid 1
Secondary, 18d exhausts culture solution, rinses, and ethanol solution is fixed, and rinses, and dyes, and is incubated for, and rinses, microscopically observation, every group random
It selects 5 visuals field, to count calcium scoring quantity under low power lens.A large amount of round coloring calcium are formed after example 6,9 dyes under microscope
Change tubercle, sharpness of border, commercially available Maotai-flavor liquor and blank group are less.Test result is as shown in table 3, it can be seen that example 6,9
Be apparently higher than the compound preparation and blank group (P < 0.05) of taurine and caffeine to the calcification of osteoblast, promote at
Bone cell proliferation.
Table 2
Number of devices and treatment scale described herein are for simplifying explanation of the invention.To application of the invention,
Modifications and variations will be readily apparent to persons skilled in the art.
Although the embodiments of the present invention have been disclosed as above, but its is not only in the description and the implementation listed
With it can be fully applied to various fields suitable for the present invention, for those skilled in the art, can be easily
Realize other modification, therefore without departing from the general concept defined in the claims and the equivalent scope, the present invention is simultaneously unlimited
In specific details and example shown and described herein.
Claims (9)
1. a kind of tablet for alleviating physical fatigue, which is characterized in that be mainly prepared from the following raw materials in parts by weight tablet:Ox sulphur
It is 400-500 parts sour, 90-110 parts of caffeine, 140-160 parts of l-Lysine hydrochloride, 45-55 parts of inositol, 30-40 parts of niacinamide, dimension
Raw element B64-6 parts.
2. alleviating the tablet of physical fatigue as described in claim 1, which is characterized in that mainly by the raw material of following parts by weight
Tablet is made:400-500 parts of taurine, 90-110 parts of caffeine, 140-160 parts of l-Lysine hydrochloride, 45-55 parts of inositol, cigarette
30-40 parts of amide, vitamin B64-6 parts, 90-110 parts of L-carnitine, vitamin B120.004-0.006 parts, vitamin B2
8-12 parts.
3. alleviating the tablet of physical fatigue as described in claim 1, which is characterized in that the tablet is chewable tablets.
4. alleviating the tablet of physical fatigue as described in claim 1, which is characterized in that mainly by the raw material of following parts by weight
Chewable tablets is made:460 parts of taurine, 100 parts of caffeine, 150 parts of l-Lysine hydrochloride, 50 parts of inositol, 35 parts of niacinamide, dimension life
Plain B65 parts, 100 parts of L-carnitine, vitamin B120.005 part, vitamin B210 parts.
5. alleviating the tablet of physical fatigue as claimed in claim 4, which is characterized in that further include the auxiliary of 250-350 parts by weight
Material.
6. the preparation process of the tablet according to any one of claims 1 to 5 for alleviating physical fatigue, which is characterized in that will be upper
The raw material sieving for stating parts by weight, mixes to obtain powder, is pelletized with the ethanol water of powder gross weight 20%, dry, whole grain will be auxiliary
Material sieving, total mix, tabletting, bottling to get.
7. alleviating the preparation process of the tablet of physical fatigue as claimed in claim 6, which is characterized in that by above-mentioned parts by weight
Raw material cross 80 meshes, mixing 30min obtains powder, is pelletized with the ethanol water of the 85wt.% of powder gross weight 20%, crosses 20 mesh
350-450 parts by weight auxiliary material is crossed 80 meshes by sieve, dry, whole grain, total mix 5min, tabletting, bottling to get.
8. alleviating the preparation process of the tablet of physical fatigue as claimed in claim 7, which is characterized in that the system of the taurine
Preparation Method is:Fish-bone is processed into fishbone dust, the distilled water of 2 times of weight is added, constant temperature decocts 2h, filtering, by filter residue at 100 DEG C
The distilled water of weight such as it is added, constant temperature decocts 2h at 100 DEG C, filters again, merges filtrate twice, concentrated by rotary evaporation to solid content
Content is higher than 50%, and into concentrate, the ethyl alcohol of the weight such as addition, adds protease, adjusts pH to 8,40 DEG C of heating water baths
2h, 100 DEG C of water-bath enzyme deactivations, centrifugal filtering liquid adjust pH to 3, and removal acidic protein precipitating adjusts pH to 10, removes alkaline egg
The distilled water of 10 times of weight is added in white precipitating, adjusts pH to 5, obtains dilution, dilution is injected light room, by etc. weight
0.25wt.%NaCl solution injects dense room, by etc. the distilled water of weight inject pole room, control light room, the water flow of dense room is
400000L/h, the water flow for controlling pole room is 200L/h, increases voltage to 20V with the speed of 2V/min, electric current no longer reduces
When, voltage, electric current 0 are adjusted, dilution carries out cation exchange treatment by treated, collects efflux, is concentrated under reduced pressure, cold
Be lyophilized it is dry to get.
9. alleviating the preparation process of the tablet of physical fatigue as claimed in claim 7, which is characterized in that the system of the caffeine
Preparation Method is:Green bamboo snake is processed into green bamboo snake powder, the distilled water of 10 times of weight is added, adding mass ratio is 1:1 CaO and
The mixture of MgO, stirring to paste are dried, and are crushed, and the volume ratio that 20 times of quality are added is 6:1 ethyl alcohol and [BMIM]+
[BH4]-Mixed solution extract 2 times, Extracting temperature be 80 DEG C, extraction time 2h, combined extract, distillation by ethyl alcohol with
[BMIM]+[BH4]-It steams, concentrated by rotary evaporation to solid content is higher than 50%, and with n-hexane extraction, 5wt.% is added in water phase
Sodium chloride solution, extracted with chloroform, merge organic phase, be concentrated under reduced pressure, freeze-drying to get.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811062445.7A CN108851089A (en) | 2018-09-12 | 2018-09-12 | Alleviate the tablet and its preparation process of physical fatigue |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811062445.7A CN108851089A (en) | 2018-09-12 | 2018-09-12 | Alleviate the tablet and its preparation process of physical fatigue |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108851089A true CN108851089A (en) | 2018-11-23 |
Family
ID=64324053
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811062445.7A Pending CN108851089A (en) | 2018-09-12 | 2018-09-12 | Alleviate the tablet and its preparation process of physical fatigue |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108851089A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109453130A (en) * | 2018-12-25 | 2019-03-12 | 白昀易 | Buccal tablet and preparation method thereof containing caffeine |
CN109998106A (en) * | 2019-04-11 | 2019-07-12 | 辽宁力克制药有限公司 | It relieves the effect of alcohol, composition for relieving physical fatigue |
CN110771901A (en) * | 2019-11-01 | 2020-02-11 | 中南粮油食品科学研究院有限公司 | Anti-fatigue hunger-resistant food additive and preparation method and application thereof |
WO2021019434A1 (en) * | 2019-07-29 | 2021-02-04 | Neilos S.r.l. | Composition for use in the prevention and/or treatment of symptoms related to tiredness and fatigue |
-
2018
- 2018-09-12 CN CN201811062445.7A patent/CN108851089A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109453130A (en) * | 2018-12-25 | 2019-03-12 | 白昀易 | Buccal tablet and preparation method thereof containing caffeine |
CN109998106A (en) * | 2019-04-11 | 2019-07-12 | 辽宁力克制药有限公司 | It relieves the effect of alcohol, composition for relieving physical fatigue |
WO2021019434A1 (en) * | 2019-07-29 | 2021-02-04 | Neilos S.r.l. | Composition for use in the prevention and/or treatment of symptoms related to tiredness and fatigue |
CN110771901A (en) * | 2019-11-01 | 2020-02-11 | 中南粮油食品科学研究院有限公司 | Anti-fatigue hunger-resistant food additive and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108851089A (en) | Alleviate the tablet and its preparation process of physical fatigue | |
WO2017124921A9 (en) | Walnut oligopeptide powder, and preparation method and application thereof | |
KR20170123534A (en) | Composition for improving sleep disturbance and sleep inducing | |
CN102101884A (en) | Preparation method and use of donkey-hide gelatin polypeptide | |
CN108144040A (en) | The cordyceps sinensis oyster peptide complexes of kidney-tonifying sperm-generating | |
CN110257459A (en) | Bird's nest small-molecular peptides and its instant Gly-His-Lys | |
US20150366896A1 (en) | Dietary composition having mixed polysaccharides derived from Lucid Ganoderma, Lycium barbarum and Polygonatum sibiricum and method of its preparation | |
CN110897147A (en) | Dendrobium officinale alcohol-dispelling and liver-protecting composition and preparation method thereof | |
CN109601795A (en) | Using penthorum chinense pursh as composition alcohol-decomposing beverage of primary raw material and preparation method thereof | |
KR20140120667A (en) | A composition comprising the extract of Salix genus plant for treating and preventing neuro-degenerative disease | |
JP2012526801A (en) | Composition for improving blood circulation containing fermented tea extract, pharmaceutical composition and fermented tea composition containing fermented tea extract | |
CN107537028B (en) | Formula for simultaneously assisting in reducing blood sugar and blood pressure and preparation method thereof | |
TW201221133A (en) | A medical compositions for inhibition of influenza Hemagglutinin and process for the preparation thereof | |
CN101779791B (en) | Composition with health care functions and preparation method thereof | |
KR20220062386A (en) | Herbal medicine extract composition having depressive mood-regulating action, manufacturing method thereof, and herbal preparation | |
CN101503727B (en) | Hyriopsis cumingii enzymolysis polypeptide, as well as preparation and application thereof | |
CN111567708A (en) | Preparation method of Chinese yam and rhizoma polygonati compound beverage | |
CN104286844A (en) | Food, health product or medicine composition capable of improving immunity | |
CN103830374A (en) | Application of three-leaf glycolipid-removal medicine in hyperuricemia | |
CN107056959A (en) | Jerusalem artichoke moderate resistance HSV 1, the composition of RSV, EV 71 and preparation | |
CN102266386B (en) | Scutellaria baicalensis extract and preparation method and uses thereof | |
CN106360180B (en) | Beverage for relieving alcoholism and preparation method thereof | |
CN110101679A (en) | Micro- effervescent tablet of seaweed sodium bicarbonate and its preparation method and application | |
KR20200061285A (en) | Food Composition for blood circulation and for Preventing blood vessel disease Comprising Extract of Galangal | |
CN109077954A (en) | Cordyceps sinensis facial mask |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |